Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 4,433

Document Document Title
WO/2019/178116A8
The present disclosure relates to the production of steviol glycosides rebaudioside J and rebaudioside N through the use of rebaudioside A as a substrate and a biosynthetic pathway involving various 1,2 RhaT-rhamnosyltransferases.  
WO/2019/195084A1
Methods of extracting Nerium oleander plant species with a plant juice or plant oil are disclosed. Pharmaceutical and cosmetic compositions comprising the resulting Nerium oleander extracts and methods of using them are also disclosed.  
WO/2019/193556A1
The invention relates to a method for extracting oligofucanes from brown algae, to the compositions resulting from said extraction, and to the applications thereof. Said method comprises the following successive steps: (a) depolymerisati...  
WO/2019/189422A1
A method for separating steviol glycoside(s), said method involving separation step 55 for performing continuous liquid chromatography wherein a liquid to be separated, which contains multiple kinds of steviol glycosides, is passed throu...  
WO/2019/152459A8
Methods for stereoselective synthesis and manufacturing of 2'-deoxynucleosides, such as 2'-ribonucleosides, are disclosed. In some embodiments, the 2'-deoxynucleoside is a β-anomer of 2'-deoxynucleoside having a 3' a hydroxyl, 4' β hyd...  
WO/2019/178980A1
A method for preparing gynostemma pentaphylla makino saponin LVI, XLVI, L, LI, Damulin A or Damulin B. In said method, Gynostemma cardiospermum Cogn.ex Oliv is used as a raw material to prepare a high content of target product by means o...  
WO/2019/179325A1
The present invention relates to the field of carbohydrate chemistry, and discloses a preparation method for a surface capsular polysaccharide structural derivative of Gram-positive bacteria. In the present invention, glucose is used as ...  
WO/2019/175126A1
The invention comprises LNA-dicarboxylic acid derivatives of the formula I or salts thereof, wherein R1 is a nucleobase or a modified nucleobase R2 is a hydroxy protecting group and n is an integer from 1 to 5. The LNA-dicarboxylic acid ...  
WO/2019/177634A1
Methods of preparing highly purified steviol glycosides, particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside A, steviolbioside B, rubusoside, stevioside, stevioside A (rebaudioside KA), stevioside B, steviosid...  
WO/2019/178116A1
The present disclosure relates to the production of steviol glycosides rebaudioside J and rebaudioside N through the use of rebaudioside A as a substrate and a biosynthetic pathway involving various 1,2 RhaT-rhamnosyltransferases.  
WO/2019/169837A1
The invention relates to an albumin conjunction-type maleimide functionalized gemcitabine prodrug as well as application thereof in transferring an antitumor prodrug. The albumin conjunction-type maleimide functionalized gemcitabine prod...  
WO/2019/169988A1
The present invention relates to the field of pharmaceutical chemistry, and in particular, to the crystal forms of Ertugliflozin and preparation methods therefor. Said crystal form is crystal form I, crystal form II or crystal form III, ...  
WO/2019/157561A1
Disclosed herein are methods and apparatuses for producing levoglucosenone and a substituted furan from lignocellulosic biomass. In one form, the method includes: converting lignocellulosic biomass, in contact with an acid within a multi...  
WO/2019/160922A1
This specification relates to a process for preparing a dried fucosyllactose (FL) from an FL solution by spray drying. This specification also relates to an FL in powder form having high bulk density, such as is obtained by the process d...  
WO/2019/154195A1
The present invention relates to a novel therapeutic drug for a neurodegenerative disease and an application thereof. Provided is a novel compound of formula (I). The compound can effectively facilitate the proliferation of neural stem c...  
WO/2019/156907A1
Disclosed are co-crystal forms of N-(2-(5-(((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6 dimethyltetra-hydro-2H-pyran-2-yl)oxy)-3'-fluoro-[1,1'-biphe nyl]-2-yl)ethyl)-acetamide and L proline or D- proline, their pharmaceutical compositions,...  
WO/2019/156483A1
The present invention relates to a method for producing a functional crystalline sweetener and, more specifically, to a method for producing a crystalline sweetener, the method being capable of improving the crystallization yield and inc...  
WO/2019/149835A1
A process for the conversion of a solid material containing hemicellulose, cellulose and lignin, which process comprises the following steps: (i) hydrolyzing, at a temperature equal to or less than 40°C, preferably equal to or less than...  
WO/2019/149833A1
A process for the conversion of a solid material containing hemicellulose, cellulose and lignin, which process comprises the following steps: (i) hydrolyzing, at a temperature equal to or less than 40°C, preferably equal to or less than...  
WO/2019/149834A1
A process for the conversion of a solid material containing hemicellulose, cellulose and lignin, which process comprises the following steps: (i) hydrolyzing, at a temperature equal to or less than 40°C, preferably equal to or less than...  
WO/2019/152459A1
Methods for stereoselective synthesis and manufacturing of 2'-deoxynucleosides, such as 2'-ribonucleosides, are disclosed. In some embodiments, the 2'-deoxynucleoside is a β-anomer of 2'-deoxynucleoside having a 3' a hydroxyl, 4' β hyd...  
WO/2019/147617A1
Novel diterpene glycosides isolated from Stevia extract as well as diterpene glycosides that are synthetically prepared are provided herein. Compositions and consumables comprising the novel diterpene glycosides are also provided herein....  
WO/2019/145713A1
The present invention relates to methods for the high fidelity synthesis of oligonucleotides and polynucleotides on a solid surface. In particular, the invention relates to methods of synthesising oligonucleotides, polynucleotides, and d...  
WO/2019/144589A1
A method for preparing high-content trehalose. The method sequentially comprises the following steps: (1) preparing starch milk; (2) liquefying; (3) performing double enzymolysis; (4) filtering to remove protein; (5) decolorizing; (6) de...  
WO/2019/145543A1
The invention comprises a process for the preparation of GalNAc oligonucleotide conjugates which comprises the coupling of a GalNAc cluster compound of the formula or corresponding salts, enantiomers and/ or a stereoisomer thereof, with ...  
WO/2019/144588A1
Disclosed in the present invention is a preparation method of large-grained trehalose, the method comprises the following steps: (1) preparing starch milk, (2) liquefaction, (3) double enzymolysis, (4) removing protein by filtration, (5)...  
WO/2019/140147A1
Methods for identifying or monitoring or treating HIV persistence or the development of an HIV-comorbidity in an HIV+ subject involve certain selected glycan dysregulations. In certain embodiments, hyposialylation in the total IgG glycom...  
WO/2019/136399A1
A synthetic dystroglycan oligosaccharide comprising Formula (I) wherein a repeating disaccharide motif consists of Glucuronic Acid (ClcA) and Xylose (Xyl) having a defined glycosyl connection GlcA-β-(1→3)-Xyl-α-(1→3)-GlcA; wherein ...  
WO/2019/128410A1
The present invention relates to the preparation of various xylan esterification products, and an application thereof in a drug for preventing, alleviating and/or treating inflammatory diseases. The application of a xylan esterification ...  
WO/2019/127004A1
The present invention falls within the field of biomedical technology, and in particular relates to modified oligonucleotides and a compound that can be used for synthesizing same, and a method for modifying oligonucleotides. The present...  
WO/2019/119134A1
An immunogenic glycan compound has a poly-β-1,4-ManNAc repeating-unit structure variably modified with 6-linked phosphoethanolamine and 6-linked phosphoglycerol.  
WO/2019/120299A1
Provided are a liver specific delivery (LSD)-based anticancer prodrug nucleoside cyclic phosphate compound and an application thereof, and in particular, a compound represented by formula (I) as well as isomers, pharmaceutically acceptab...  
WO/2019/119628A1
Disclosed in the present invention is a method for preparing tulathromycin.  
WO/2019/122084A1
It relates to a process for the preparation of nicotinamide riboside chloride of formula (I) wherein R1-R4 are as defined herein, comprising the following steps: a) reacting a riboside precursor wherein the hydroxyl groups at positions 1...  
WO/2019/118476A1
The presently disclosed subject matter relates to processes for isolating xylose from an aqueous solution. A representative process can comprise providing an aqueous solution comprising xylose; combining a boron compound with the aqueous...  
WO/2019/114406A1
An absorbable iron-based implantable device, comprising an iron-based substrate and a hydrophobically-modified high polysaccharide attached to the iron-based substrate. The solubility of the modified high polysaccharide in an organic sol...  
WO/2019/110804A1
Disclosed is a method for the manufacture of a spray-dried powder consisting essentially of LNT and/or LNn T, the spray-dried powder, its use for the manufacture of nutritional compositions, and nutritional compositions containing the sp...  
WO/2019/110806A1
Disclosed is a method for the manufacture of a spray-dried powder consisting essentially of at least one lacto-N-fucopentaose, the spray-dried powder, its use for the manufacture of nutritional compositions, and nutritional compositions ...  
WO/2019/110803A1
Disclosed is a method for the manufacture of a spray-dried powder consisting essentially of 3'-SL and/or 6'-SL, the spray-dried powder, its use for the manufacture of nutritional compositions, and nutritional compositions containing the ...  
WO/2019/109300A1
Improved enrichment methods for preparing tannic acid compositions that have superior potency in inhibiting D-amino acid oxidase, and superior purity and safety profiles. The tannic acid compositions (e.g., pharmaceutical compositions, n...  
WO/2019/110801A1
Disclosed is a method for the manufacture of a spray-dried powder consisting essentially of 3-fucosyllactose, the spray-dried powder, its use for the manufacture of nutritional compositions, and nutritional compositions containing the sp...  
WO/2019/109833A1
The present utility model provides a device for continuously producing sugar by hydrolyzation using a lignocellulosic raw material. The device comprises: an acid liquid outputting unit, a raw material mixing unit, a feeding unit, a main ...  
WO/2019/113032A1
High surface area metal catalysts, and methods of making and using the same, are described.  
WO/2019/110800A1
Disclosed are spray-dried powders containing a mixture of structurally distinct human milk oligosaccharides, methods for the production of said spray-dried powder, its use for the manufacture of nutritional compositions, and nutritional ...  
WO/2019/106192A1
Saponin extracts containing at least 93% QS-21 main peak and 0.25-3% 2018 component by UV absorbance at 214 nm, methods for making said extracts, their use as vaccine adjuvants and related aspects.  
WO/2019/106564A1
Methods and systems are disclosed for selectively removing naturally-occurring sugars in beverages in an effective, affordable and scalable manner.  
WO/2019/101629A1
The present invention concerns an efficient way to isolate L-fucose from a fermentation broth. The L-fucose contained in the fermentation broth is produced by microbial fermentation (bacterial or yeasts). The inventive process comprises ...  
WO/2019/100920A1
Disclosed is a method for the rapid preparation of an oligosaccharide from a biomass sugar as a raw material. In the method, biomass sugar is placed in a quartz tube tubular reactor, and under the protection of nitrogen, the quartz tube ...  
WO/2019/104253A1
Novel cultivars of Stevia rebaudiana plant, with a novel genetic trait of self-compatibility, and the advantageous use of this genetic trait in Stevia rebaudiana crossing breeding for increasing steviol glycosides production, including f...  
WO/2019/101489A1
The present invention describes an efficient way to isolate a sialic acid from a fermentation broth. The sialic acid contained in the fermentation broth is produced by bacterial fermentation. The inventive process comprises a step of rem...  

Matches 1 - 50 out of 4,433